- New Brunswick reported three fatalities, a rise in newly positive tests, and a drop in hospitalizations in its most recent COVID-19 update.
- Additionally, 27% of the samples were from the more recent BA. The BA consisted of 4 subvariants and 18% of the sample. Five distinct.
- 52.8 percent of New Brunswick citizens have had a booster shot, and 88.2 percent have received two doses of the COVID-19 vaccine.
In its most recent COVID-19 update, New Brunswick reported a decrease in hospitalizations, a spike in newly positive tests, and three fatalities.
Six new hospital admissions occurred between June 19 and June 25, which decreased from the previous week’s total of 17 new admissions. With one patient in the ICU, there are currently 15 active hospitalizations, 10 less than the previous week.
According to the weekly data, those between the ages of 60 and 79 account for most COVID-19 hospitalizations.
The province recorded three further deaths associated with COVID-19: one in their 70s and two in their 90s. COVID-19 has now claimed the lives of 425 persons in New Brunswick.
There were no further deaths recorded during the most recent reporting period.
In addition, 484 new positive PCR tests have been reported in the past week, up from 425 the week before. Additionally, 541 additional new cases—up from 403 in the previous update—have been discovered through quick tests.
A rise from the 618 active cases reported the previous week to an anticipated 657 active cases in New Brunswick.
In the most current random samples sequenced for COVID-19, 55% of the samples included the more transmissible BA.2 subvariant of the Omicron variant.
Additionally, the more recent BA made up 27% of the samples. 18% of the sample and 4 subvariants made up the BA. 5 different.
The combination of BA.4 and BA.5, according to Dr. Jennifer Russell, the province’s chief medical officer of health, are starting to predominate strains and are predicted to keep expanding since they are more contagious than the BA.2 subvariant.
According to definition, a variety of concerns is a strain that possesses additional traits that could lead to increased immune evasion, transmissibility, or severity.
It’s too soon to say for sure, according to Russell, whether the newly discovered subvariants will increase hospital admissions.
“It might occur. We hope not. But as of now, they’re anticipating a wave at the national level in the early to mid-fall,” she said. But once more, we are looking at real-time data, not models.
She stated that fading immunity is one of the main issues with the subvariants.
We do notice some diminishing in those who received their final vaccination dosage several months ago, she added. “So right now is a perfect time. You should acquire your second booster if you haven’t already.
For those 50 years and older, as well as First Nations people 18 years and older, a second booster dose is currently available.
To extend second booster doses to other age groups, Russell said the province is awaiting recommendations from the National Advisory Committee on Immunization.
Currently, 88.2% of New Brunswick residents have had two doses of the COVID-19 vaccination, and 52.8% have had a booster shot.
Source: Global News
Get Canada and New Brunswick News’s top News, Market news, and other worldwide news only on New Brunswick Tribune.